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Abstract:  
Background: Few studies report on experience of care for Parkinson’s disease (PD) from 
patients’ own point of view.   
Methods: Analysis of a survey in 11 European countries on self-reported access to services 
and satisfaction with different aspects of care.  
Results: 1,775 people with PD (PwP) participated with disease duration ranging from <1 to 
42 years. Initial referral to specialists had taken <3 months in most but medication reviews 
occurred every 3 months in only 10%, every 6 months in 37%, once a year in 40%, and every 
two years or less frequently in 13%. Waiting times to therapists were usually at ≥4 months. 
Satisfaction with care was highest for involvement of PwP in decisions (63% of respondents 
satisfied) and involvement of family/carer (62%) followed by communication with PwP 
(57%), information received (54%), frequency of treatment reviews (52%), suitability of 
treatment for the individual condition and circumstances (52%), but lowest for availability 
and accessibility of treatment when needed (48%) and collaborations between healthcare 
professionals in delivering care (41% satisfied). The main factors associated with overall 
satisfaction scores with care were the overall satisfaction with initial consultation (r=0.26, 
p<0.0001), the sensitivity with which the diagnosis was communicated, the quantity of 
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information provided (both r=0.24, p<0.0001) and the frequency of medication review 
(r=0.17, p<0.0001). 
Conclusion: More coordinated and responsive care, tailored to the individual, with regular 
and timely medication reviews and treatment referrals, is likely to improve satisfaction with 
care in current health care pathways.   
 
Introduction 
There is an increasing emphasis on patient experiences of care in health care systems (1;2), 
which may inform provision of care to meet the needs of patient populations. In Parkinson’s 
disease (PD) satisfaction with care is also associated with better quality of life (3;4). 
However, there is currently limited information on patients’ experiences of care and areas of 
unmet needs from the patients’ point of view in PD. “My PD Journey” is an initiative by the 
European Parkinson’s Disease Association (EPDA) to identify current gaps in Parkinson’s 
care from the point of view of people with Parkinson’s (PwP; http://www.epda.eu.com/get-
involved/my-pd-journey/). We here report the experience of, and satisfaction with, different 
aspects of care across 11 European countries from a large quantitative survey in the “My PD 
Journey” project.  
 
Methods 
A survey was conducted between 1st November 2014 and 12th January 2015 through the 
EPDA’s national patient organisations in PwPs from eleven countries (Denmark, France, 
Germany, Hungary, Ireland, Italy, Netherlands, Slovenia, Spain, Sweden, and UK).  Patients 
who volunteered to participate completed a self-report online survey on their experiences of 
care pathways (except in Slovenia where, due to low Internet access, hard copies of the 
survey were distributed via the national Parkinson’s Association to their members). 
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Measures 
The survey questions were drafted based on a stakeholder meeting of EPDA members from 
30 European countries, and aimed to gather information about the current state of the 
Parkinson's care pathways in the eleven countries. The original survey was developed in 
English, with the language designed to ensure that the survey would not elicit biased 
responses by the way the questions were phrased. The survey questions were translated into 
equivalent meaning in each country’s language. The draft questionnaire was reviewed by 
members of the International Parkinson and Movement Disorders Society European Section 
and EPDA members from the participating European countries to ensure it covered the main 
relevant areas. The survey was pre-tested with a selected group of PwPs (of differing ages 
and years since diagnosis), to ensure that the survey questions were interpreted correctly. 
The final version of the questionnaire included questions on demographics, residency, 
employment and disease duration, self-rated Schwab and England disability, type of 
healthcare professionals seen, waiting times and treatments given, frequency of medication 
reviews, information received and experiences of and satisfaction with health care. Frequency 
of medication review was collected by type of healthcare professionals with the following 
answer options: ‘every 3 months’, ‘every 6 months’, ‘once a year’, ‘once every two years or 
more’, ‘do not know’ and ‘does not apply’. Information received was collected by type of 
information (symptoms, diagnosis and causes of PD, medication, surgical treatments, non-
drug treatments, maintaining physical and emotional wellbeing, financial help available, 
support organisations, support for carers, where to find more information on PD, and taking 
part in clinical trials), and a summary score created for quantity of information provided. 
Satisfaction with care was assessed in relation to i) care received from nine different clinical 
professions (general practitioner or family doctor, hospital doctor, general neurologist, care of 
the elderly doctor (geriatrician), neurologist who is a specialist in Parkinson’s, Parkinson’s 
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nurse specialist (PDNS), physiotherapist, occupational therapist (OT), speech and language 
therapist), ii) eight different aspects of care (How often your treatment plan is reviewed, The 
way professionals communicate with you about your condition and treatment options, The 
information you have received from healthcare professionals, Your level of involvement in 
decisions about your treatment, Your family’s/carer’s level of involvement in decisions about 
your treatment, The availability and accessibility of suitable treatment options when you need 
them, The suitability of your treatment for your condition and circumstances, The way the 
various professionals work together to deliver your treatment and care). Participants were 
also asked about satisfaction with initial diagnostic consultation and sensitivity of 
communication of diagnosis. All responses were rated on a Likert scale from 1 (‘very 
dissatisfied’) to 5 (‘very satisfied’), except sensitivity of diagnosis, which was measured from 
1 (‘not at all sensitively’) to 4 (‘very sensitively’). Answers of ‘does not apply’ were treated 
as missing data.   
As this was a survey by a patient organisation on care experiences, no ethics committee  
review was required.  Informed patient consent was not applicable for this study. 
 
Data analysis  
Descriptive results are presented with total numbers and percentages and mean with standard 
deviation (SD) or median (range), if not normally distributed. Data were tested for normality 
using the Kolmogorov-Smirnov Test. Principal components analysis was conducted on the 8 
items on satisfaction with aspects of care to determine if a summary score for this item could 
be created. As all items of the eight aspects of care loaded on one factor with small 
differences between the factor loadings (see supplementary material, table 1), a total score for 
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overall satisfaction with care was created as an average of all items on aspects of care (range 
1 - 40).    
Correlations between variables were examined using bivariate Pearson correlations, and 
independent samples Chi-square and t-tests were calculated to explore any significant 
differences between groups. For data that were not normally distributed, non-parametric 
alternatives were used i.e. Spearman correlations, Kruskal-Wallis H and Mann-Whitney U 
tests using a significance level of 5%. Comparisons between countries were adjusted with the 
Bonferroni correction for multiple comparisons between 11 countries and the type of health 
care professionals. All analysis was conducted using SPSS (version 21). 
 
Results  
Participants  
1,775 adults (958 males, 817 females) participated with an average age at diagnosis of 58 
(range 25 to 90; table 1). Years since diagnosis spanned from less than one year to 42 years 
(figure 1). A large proportion of the sample was from Sweden (46%), and we therefore 
conducted a sensitivity analysis of the sample excluding the Swedish sample. The Swedish 
population had an earlier age of onset (56.7 years vs 60.5 years), had higher rates of 
employment (20.9% vs 16.3%), and fewer people living in cities (45.1% vs 27.2%) than the 
non-Swedish population (see supplementary material, table 2).   
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Provision of Care 
Diagnosing clinician and referral times 
Of the 1485 respondents who answered this question, 5% reported that they had been 
diagnosed by a general practitioner (GP), 34% by a general neurologist, 52% by a specialist 
neurologist, 4% by a hospital doctor, and 1% by a geriatrician with the remaining 4% stating 
‘other’. In all of the 11 European countries the majority reported they had been diagnosed by 
a specialist neurologist, except in France, Germany, and Spain where the majority were 
diagnosed by a general neurologist (p<0.0001).   
If they were referred to another specialist, waiting times varied between <1 month to >4 
months to see a general neurologist or specialist PD neurologist, but were generally longer to 
see a geriatrician, a PDNS or a therapist, with waiting times of >4 months for most healthcare 
professionals (figure 2 and supplementary material, figure 1). Waiting times to see a 
specialist PD neurologist were similar between all countries; however there were some 
differences in waiting times to see a therapist, a PDNS or general neurologist between 
countries (supplementary material 2).   
Medication reviews 
74% of the 1328 who responded to this question reported that they had medication reviews 
by a specialist PD neurologist, 30% by a general neurologist, 23% by a PDNS, 18% by a GP, 
9% by a hospital doctor and 5% PwPs had reviews by a geriatrician. Overall, 10% reported 
their medication is reviewed by any health care professional every 3 months, 37% every six 
months, 40% once a year and 13% once every two years or more (table 2). In Sweden, 
medication reviews were more frequent than in the other countries across all health care 
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professions (all p<0.0001) except by geriatricians. The frequency of review by country is 
shown in table 3 supplementary materials and by health care professional in table 3.    
 
Satisfaction with care  
Satisfaction with care by aspect of care 
Almost two thirds of participants reported satisfaction for how involved patients felt in 
decisions on their treatment (n = 819/1304, 63% of respondents who answered this question) 
and for their family’s/carer’s level of involvement with decisions about treatment (667/1079, 
62%), followed by the way healthcare professionals communicated with PwPs about their 
condition and treatment options (722/1265, 57%), and information received from healthcare 
professionals (689/1269, 54%; figure 3). Approximately half (663/1270; 52%) were satisfied 
with how often their treatment plan was reviewed and with the suitability of their treatment 
for their condition and circumstances (665/1288; 52%) and 564/1181 (48%) were satisfied 
with the availability and accessibility of suitable treatment options when they need them. 
Satisfaction was lowest (462/1114, 41%) for patients’ perception of the way the various 
health care professionals work together to deliver treatment and care. In the sensitivity 
analysis, in both the Swedish (59%) and non-Swedish sample (67%), satisfaction was highest 
for how involved patients felt in decisions on their treatment and lowest for the way various 
health care professionals work together to deliver treatment and care (32% in the Swedish 
and 49% in the non-Swedish sample). 
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Level of satisfaction with aspects of care by country is shown in supplementary material, 
figure 2. All countries were most often satisfied with how involved patients felt in decisions 
on their treatment, except in Hungary (the way healthcare professionals communicated with 
PwPs about their condition and treatment options, 84% satisfied), France (how often their 
treatment plan was reviewed, 78%), Slovenia (information received from healthcare 
professionals, 65%), Spain (family’s/carer’s level of involvement with decisions about 
treatment, 57%), and Italy (availability and accessibility of suitable treatment options when 
they need them, 33%).   
All countries were most often dissatisfied with the way various health care professionals 
work together to deliver treatment and care, except in Slovenia (45%) where they were most 
often dissatisfied with how often their treatment plan is reviewed and in Italy (14%) where 
they were most often dissatisfied with their carer’s level of involvement in decisions about 
treatment.    
Satisfaction with care by profession 
The highest satisfaction levels with overall care were reported with care received from 
Physiotherapists (n = 639, 77% of respondents), followed by specialist neurologists (819, 
73%) and 534 (73%) from a PD Nurse specialist. 602 (60%) of PwPs reported that they were 
satisfied with the care they received by their GP, 219 (52%) from their hospital doctor, 372 
(57%) from their general neurologist, and 73 (49%) were satisfied with the care they received 
from their geriatrician (figure 4). In the sensitivity analysis, whilst the Swedish respondents 
were most satisfied with the care received from specialist neurologists (76% satisfied) and 
lowest for hospital doctor (44%), the non-Swedish sample reported that they were most 
satisfied with care received from physiotherapists (80%) and least satisfied with geriatricians 
(44%).  
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Satisfaction with care by healthcare profession between countries is shown in supplementary 
material, figure 3). 
Correlates of overall satisfaction with care 
There was no significant correlation between overall satisfaction with care and age, and there 
was no difference between genders, between employed or unemployed participants, and 
between rural, town and city dwellers in satisfaction with care. There were weak positive 
correlations between satisfaction with care and disease duration (r=0.14, p<0.0001 and some 
aspects of care and level of disability, and between overall satisfaction with care and 
frequency of medication reviews (r=0.17, p<0.0001). Overall satisfaction with care was not 
associated with waiting times to see another specialist. There were positive correlations, with 
satisfaction with the initial consultation (r=.26, p<0.0001), with how sensitively patients were 
told they had PD (r=.24, p<0.0001) and with the quantity of information provided (r=.24, 
p<0.0001). In the sensitivity analysis, similar correlations were reported in the Swedish and 
non-Swedish respondents.   
Discussion 
Experiences of care varied considerably between respondents. The majority reported waiting 
times of less than 4 months if they had been referred to a general neurologist or specialist PD, 
although a substantial proportion reported having waited longer. The frequency of 
subsequent, ongoing reviews by specialists was then much less frequent in the majority, 
typically once or twice a year with a minority seeing a specialist more frequently. 13% were 
reviewed only every two years or less often. Waiting times to see therapists or PDNS, where 
available, were often long, reflecting the limited availability of PDNS and lack of resources 
for allied health care professionals (5). However, this was not associated with reported 
overall satisfaction with care. Satisfaction with care received by PwP was highest for how 
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health professionals involve PwP, and their families or carers, in decisions on their treatment, 
how they communicate with them about their condition and treatments, and with the 
information they provide. Whilst there is no previous survey to our knowledge that assessed 
satisfaction with involvement in treatment decisions in PD, in a previous survey by the EPDA 
in Europe(6) 11.6% of participants reported that they made treatment decisions on their own 
and 50.6% together with their healthcare professional. It could be argued that those reporting 
not being involved in these decisions prefer for them to be made by healthcare professionals. 
However, this contrasts with the finding in this survey that only 63% were satisfied with their 
involvement in these decisions, highlighting that there is still a continued need to increase 
patient participation in management decisions in PD. As the survey represents the cumulative 
experience of PwP over an average of ~8 years disease duration, this may have improved 
more recently but it is likely that many still perceive lack of sufficient involvement of their 
own and their carers’ views, and lack of information being provided.  
Approximately half of all participants reported satisfaction with the frequency of reviews of 
their medication, with how the treatments given were suited to their personal needs, and with 
the availability and accessibility of treatments when needed. These opinions on the provision 
of health care, mirroring the often very infrequent reviews reported by participants and the 
long referral times to other health care professionals and therapists, highlight the impact of 
lack of resources to provide regular reviews particularly with advancing disease, access to 
therapists to respond to an individual’s needs on a personalised basis, and prevent 
deterioration, and a personalised, responsive system to address complications when they 
occur. It also highlights that only half of PwP feel that a personalised approach, suited to the 
individual’s condition and circumstances as opposed to a standardised approach for PD, is 
insufficiently provided.  
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The poorest satisfaction rating was however reported for the way professionals work together 
to provide care. This is particularly relevant at times when exacerbations occur, and it reflects 
the lack of joined-up and integrated care across services for PD in many health care systems. 
This is notable as integrated care with increasing emphasis on multidisciplinary approaches is 
a key aim for many health care systems, with evidence suggesting better outcomes, greater 
satisfaction and cost savings (7-11).  
The low satisfaction with a personalised, responsive and integrated approach to the care of 
PwP is also at odds with an increasing emphasis on patient-centered care in modern health 
care systems. Key components of patient-centered care have been outlined as including 
greater emphasis on patient and caregiver perspectives and priorities, and efforts to close gaps 
in knowledge among patients and caregivers in a variate of aspects (12). Whilst there is 
considerable variability in preferences for decision making and provision of communication 
(13), studies have outlined that, in addition to addressing their motor and non-motor 
problems, PwP want their physicians to listen to them and take their concerns seriously, 
improving two-way communication between patient and physician, to explain their disease 
comprehensively, and to provide the latest information on PD and its treatment, while also 
taking into account their anxiety toward the future, communication difficulties, and slowness 
(14). However, addressing these issues often takes additional time, which can be difficult to 
provide in a general neurology clinic, or requires additional appointments, e.g. with a PDNS 
or other health care professional.  In more advanced disease, with more complex needs 
requiring a multidisciplinary approach, the need for greater integration of services was 
highlighted in a Dutch study in nursing homes, which found that poor access to specialists 
and coordination of care was one of the unmet needs together with the need for emotional 
support and improved knowledge of PD(15). Whilst there was only a weak correlation 
disease duration with overall satisfaction with care, easier and better communication between 
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health care professionals is particularly relevant with advancing disease when timely 
intervention for often complex needs is often needed and information needs to be 
communicated between different health care professionals. We did not collect health 
economic data, but it is highly likely that the poor communication and integration of care 
between health care professionals also results in increased costs through hospital admissions 
and deterioration of symptoms.  
There were significant correlations of overall satisfaction with care with frequency of 
medication review, possibly as a marker of accessibility of care, and with the initial 
diagnostic experience, including how the diagnosis was communicated; despite the fact that 
average disease duration was over 8 years. Whilst the causality in a cross sectional survey 
cannot be established and those overall unhappier with treatment may also have viewed their 
initial experience more negatively, this emphasises the importance of the initial consultation 
and the need to communicate the diagnosis sensitively. 
Little previous information on these aspects of health care provision is available in PD 
although there is evidence from other disorders that outcomes can be improved through 
integrated working(10) with increasing efforts to improve collaborative working(16).  
A previous US-based study surveyed members of a US Parkinson’s registry(17), showed 
similar results to this survey in Europe. Whilst many of the questions were not directly 
comparable, the results on communication and information by health care professionals about 
PD and medications in this study were overall also relatively high (56% vs approximately 
80% in this survey), and there was greater overall satisfaction with PD specialists than 
general neurologists. In both surveys fewer respondents were satisfied with information on 
non-drug treatments (28% vs 41%). despite increasing recognition of the importance of these 
aspects (18).  
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Limitations 
Participants were recruited through volunteers from national organisations and, particularly 
as we do not have information on non-participants, may therefore be biased towards more 
active and engaged PwP, and towards those actively seeking greater involvement in their 
care. Satisfaction with information and involvement may be higher in those who seek less 
active engagement, but this group may also be more dependent on better communication of 
health care professionals. Furthermore, nearly half of all respondents on the survey were from 
Sweden. However, when excluding the Swedish sample from the analysis, the results were 
overall comparable. Nevertheless, due to the relatively small number of participants in each 
of the other countries, the retrospective nature of the survey and possible differences in 
recruitment bias, results of differences between countries should be interpreted cautiously. 
We had no possibility of verifying the diagnostic accuracy in those who completed the 
survey. However, it is unlikely that, given the large sample, the results would vary 
significantly of only those with a confirmed diagnosis were included. In addition, the range of 
disease duration ranged from very early disease (<1 year) to very long standing disease 
duration (>40 years) and it is likely that the results of this survey are representative for PwP 
across disease stages.  
Whilst acknowledging the limitations of the nature of this survey, this large survey of the 
experiences of PwP in Europe suggests that despite the increasing constraints in health care 
systems, there is a need to adjust health care services for PwP, e.g. by providing more flexible 
appointments, increasing provision of information in PD and its management to PwP and 
non-specialist health care professionals, and improving links between healthcare 
professionals. This has the potential to substantially improve satisfaction with care in PwP, 
with limited need for additional resources.  
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Figure 1. 
Waiting times to see different health care professionals from referral  
*PD – Parkinson’s Disease, PDNS – Parkinson’s Disease Nurse Specialist, OT – Occupational therapist, 
SPAL – Speech and language therapist 
 
Figure 2. 
Satisfaction with care by aspects of care 
 
Figure 3. 
Satisfaction with care by provider 
*GP – General practitioner, PDNS – Parkinson’s Disease Nurse Specialist, OT – Occupational 
therapist, SPAL – Speech and language therapist 
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Table 1. Demographic and clinical characteristics of participants  
Mean (SD) 
Age of onset 58.5 (10.0)  
Male:Female (n (%)) 958 (54): 817 (46) 
Employed (n (%)) 333 (18.8) 
Years since diagnosis 8.2 (6.1) 
Disability level (Median (Range)) 80 (0-100.0) 
Country (n (%)): 
UK 110 (6.3) 
Holland 175 (10.1) 
Denmark 146 (8.4) 
France 47 (2.7) 
Hungary 66 (3.8) 
Germany 84 (4.8) 
Spain 64 (3.7) 
Slovenia 90 (5.2) 
Italy 151 (8.7) 
Sweden 806 (46.3) 
Habitat (n (%)): 
Rural 343 (19.4) 
Town 655 (37.0) 
City 774 (43.7) 
 
 
 
 
 
Table 2. Frequency of medication reviews by clinician (n= 1328*) 
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GP (%) 
Hospital 
Doctor 
General 
Neurologist 
Specialist PD 
neurologist Geriatrician 
PD 
Nurse Any (%) 
Once every 
2 years or 
more 80 (34) 24 (19) 88 (22) 137 (14) 10 (15) 56 (18) 173 (13)
Once a year 63 (27) 43 (35) 162 (40) 412 (42) 21 (31) 
112 
(36) 526 (40)
Every 6 
months 73 (31) 45 (36) 120 (30) 360 (36) 31 (45) 
114 
(37) 488 (37)
Every 3 
months 20 (8) 11 (10) 31 (8) 75 (8) 6 (9) 29 (9) 141 (10)
 
*excluding missing data 
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